Precigen (PGEN) EBT Margin (QoQ) (2012 - 2026)
Powered by 
Analysis
Precigen (PGEN) EBT Margin (QoQ) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.26 Bn | 9.41 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.18 Bn | 5.18 Bn | - |
| 3 | Iovance Biotherapeutics | 3.82 Bn | 3.52 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.67 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.98 Bn | 1.81 Bn | 56.40 Mn |
| 10 | Taysha Gene Therapies | 1.97 Bn | 1.97 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7,061.00 |
| Mar 31, 2026 | 48,075.00 |
| Dec 31, 2025 | 449,350.00 |
| Sep 30, 2025 | -189,632.00 |
| Jun 30, 2025 | 92,622.00 |
| Mar 31, 2025 | -237,321.00 |
| Dec 31, 2024 | 84,975.00 |
| Sep 30, 2024 | 592,049.00 |
| Jun 30, 2024 | -620,364.00 |
| Mar 31, 2024 | 48,725.00 |
| Dec 31, 2023 | -128,300.00 |
| Sep 30, 2023 | -28,230.00 |
| Jun 30, 2023 | 7,758.00 |
| Mar 31, 2023 | 2,623.00 |
| Dec 31, 2022 | -121,139.00 |
| Sep 30, 2022 | 85,224.00 |
| Jun 30, 2022 | -46,371.00 |
| Mar 31, 2022 | 28,981.00 |
| Dec 31, 2021 | 6,713.00 |
| Sep 30, 2021 | 2,108.00 |